Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by <i>P. aeruginosa</i> Isolated from Cystic Fibrosis Patients
(1) Background: Cystic fibrosis (CF) is characterized by chronic pulmonary inflammation and persistent bacterial infections. <i>P. aeruginosa</i> is among the main opportunistic pathogens causing infections in CF. <i>P. aeruginosa</i> is able to form a biofilm, decreasing ant...
Saved in:
Main Authors: | Arianna Pani (Author), Valeria Lucini (Author), Silvana Dugnani (Author), Alice Schianchi (Author), Francesco Scaglione (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for <i>Pseudomonas aeruginosa</i> Cystic Fibrosis Lung Infections
by: Giovanni Di Bonaventura, et al.
Published: (2024) -
Virulence of <i>Pseudomonas aeruginosa</i> in Cystic Fibrosis: Relationships between Normoxia and Anoxia Lifestyle
by: Rosanna Papa, et al.
Published: (2023) -
XDR-<i>Pseudomonas aeruginosa</i> Outside the ICU: Is There Still Place for Colistin?
by: Paola Del Giacomo, et al.
Published: (2022) -
Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021) -
Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of <i>Pseudomonas aeruginosa</i> under Conditions Relevant to Cystic Fibrosis
by: Giovanna Batoni, et al.
Published: (2023)